Real-time enrollment status for this liposarcoma clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:06 PM UTC
| NCT Number | NCT04557449 |
| Recruiting Status | Recruiting |
| Condition | Liposarcoma |
| Phase | PHASE1 |
| Target Enrollment | 430 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | October 21, 2026 (22 hours ago) |
As of October 21, 2026: Clinical trial NCT04557449 is currently recruiting participants. This phase1 study for liposarcoma is actively seeking new participants at 14 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04557449 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04557449 was last updated 22 hours ago (October 21, 2026). HelloStudys verifies this status automatically.